Table 2.
Non-user | 1–2 prescriptions/year | >2 prescriptions/year | p Value | |
Any antidepressant | ||||
n | 1934 | 188 | 212 | |
Baseline weight (kg), mean (SD) | 80.0 (17.0) | 77.1 (16.5) | 81.3 (19.1) | |
Follow-up weight (kg), mean (SD) | 80.6 (17.3) | 78.0 (17.2) | 82.5 (19.6) | |
Annual weight change (kg), mean (SD) | 0.12 (1.32) | 0.18 (1.54) | 0.28 (1.99) | |
Model 1* | Ref | 0.15(−0.06 to 0.36) | 0.22 (0.02 to 0.42) | 0.022 |
Model 2† | Ref | 0.18(−0.04 to 0.40) | 0.25 (0.04 to 0.46) | 0.009 |
Model 3‡ | Ref | 0.11(−0.11 to 0.34) | 0.22 (0.00 to 0.44) | 0.044 |
SSRIs | ||||
n | 2109 | 114 | 111 | |
Baseline weight (kg), mean (SD) | 79.8 (17.0) | 79.7 (18.2) | 82.2 (19.1) | |
Follow-up weight (kg), mean (SD) | 80.3 (17.3) | 81.2 (18.0) | 84.9 (21.2) | |
Annual weight change (kg), mean (SD) | 0.11 (1.33) | 0.38 (2.11) | 0.61 (1.89) | |
Model 1* | Ref | 0.30 (0.04 to 0.57) | 0.53 (0.27 to 0.80) | <0.001 |
Model 2† | Ref | 0.30 (0.03 to 0.58) | 0.58 (0.30 to 0.85) | <0.001 |
Model 3‡ | Ref | 0.30 (0.01 to 0.58) | 0.48 (0.20 to 0.76) | <0.001 |
TCAs | ||||
n | 2212 | 79 | 43 | |
Baseline weight (kg), mean (SD) | 80.1 (17.2) | 76.3 (17.8) | 77.3 (15.9) | |
Follow-up weight (kg), mean (SD) | 80.8 (17.5) | 75.5 (17.3) | 77.3 (16.4) | |
Annual weight change (kg), mean (SD) | 0.16 (1.40) | −0.13 (1.61) | −0.01 (1.32) | |
Model 1* | Ref | −0.12(−0.44 to 0.19) | 0.06(−0.36 to 0.49) | 0.717 |
Model 2† | Ref | −0.11(−0.44 to 0.22) | 0.05(−0.39 to 0.50) | 0.704 |
Model 3‡ | Ref | 0.02(−0.31 to 0.36) | 0.03(−0.46 to 0.52) | 0.908 |
Other antidepressants | ||||
n | 2210 | 57 | 67 | |
Baseline weight (kg), mean (SD) | 79.8 (17.0) | 80.0 (18.7) | 82.9 (20.5) | |
Follow-up weight (kg), mean (SD) | 80.4 (17.4) | 81.3 (17.6) | 83.4 (21.2) | |
Annual weight change (kg), mean (SD) | 0.14 (1.37) | 0.35 (1.88) | 0.12 (2.08) | |
Model 1* | Ref | 0.23(−0.13 to 0.60) | −0.04(−0.38 to 0.29) | 0.844 |
Model 2† | Ref | 0.32(−0.05 to 0.70) | −0.01(−0.36 to 0.35) | 0.505 |
Model 3‡ | Ref | 0.42 (0.03 to 0.80) | −0.19(−0.56 to 0.19) | 0.926 |
*Model 1 adjusted for age and gender.
†Model 2 further adjusted for baseline income, smoking, physical activity, follow-up duration.
‡Model 3 further adjusted for depression status at baseline and follow-up, dietary patterns (continuous).
SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant.